Pharma Import Alert: FDA Working Towards Consistency, Better Decision Making
This article was originally published in PharmAsia News
Executive Summary
FDA’s broad reorganization may not create the same super-specialization for the import staff that is coming to other parts of the agency, but a process overhaul appears on its way regardless.
You may also be interested in...
FDA Secure Supply Chain Pilot Draws Small Group, But Could Serve Globalization Goals
Agency planned for up to 100 participants in program allowing expedited entry of some imports, but only approved 13.
FDA Reorganization To Focus On Employee Specialization
Agency’s Program Alignment Group recommends “commodity-based and vertically-integrated programs” to improve efficiency and communication.
FDA’s PREDICT Import Screening System Working As Predicted
An initial look at data from the first year of the import screening system’s full operation finds PREDICT is effective in directing FDA inspectors to high-risk products, Deputy Associate Commissioner for Regulatory Affairs Steve Solomon says.